{"id":"https://openalex.org/W2808748844","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p4.105","title":"Efficacy of Erenumab for the Treatment of Patients with Episodic Migraine with Depression and/or Anxiety (P4.105)","display_name":"Efficacy of Erenumab for the Treatment of Patients with Episodic Migraine with Depression and/or Anxiety (P4.105)","publication_year":2018,"publication_date":"2018-04-10","ids":{"openalex":"https://openalex.org/W2808748844","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p4.105","mag":"2808748844"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.90.15_supplement.p4.105","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p4.105","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.90.15_supplement.p4.105","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064341657","display_name":"Stewart J. Tepper","orcid":"https://orcid.org/0000-0002-9879-6638","observed_orcids":["https://orcid.org/0000-0002-9879-6638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stewart Tepper","raw_affiliation_strings":["Geisel School of Medicine At Dartmouth Lebanon NH United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geisel School of Medicine At Dartmouth Lebanon NH United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045656538","display_name":"Gregor Broessner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I143397708","display_name":"Innsbruck Medical University","ror":"https://ror.org/03pt86f80","country_code":"AT","type":"education","lineage":["https://openalex.org/I143397708"]},{"id":"https://openalex.org/I190249584","display_name":"Universit\u00e4t Innsbruck","ror":"https://ror.org/054pv6659","country_code":"AT","type":"education","lineage":["https://openalex.org/I190249584"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Gregor Broessner","raw_affiliation_strings":["Department of Neurology, Medical University of Innsbruck Innsbruck Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Medical University of Innsbruck Innsbruck Austria","institution_ids":["https://openalex.org/I143397708","https://openalex.org/I190249584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102856766","display_name":"Dawn C. Buse","orcid":"https://orcid.org/0000-0002-1223-1215","observed_orcids":["https://orcid.org/0000-0002-1223-1215"]},"institutions":[{"id":"https://openalex.org/I1335289525","display_name":"Montefiore Medical Center","ror":"https://ror.org/044ntvm43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335289525","https://openalex.org/I19772626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dawn Buse","raw_affiliation_strings":["Montefiore Headache Center Bronx NY United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Montefiore Headache Center Bronx NY United States","institution_ids":["https://openalex.org/I1335289525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019480561","display_name":"Todd J. Schwedt","orcid":"https://orcid.org/0000-0002-7780-7086","observed_orcids":["https://orcid.org/0000-0002-7780-7086"]},"institutions":[{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd Schwedt","raw_affiliation_strings":["Mayo Clinic Phoenix AZ United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Phoenix AZ United States","institution_ids":["https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Erik Strauss","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erik Strauss","raw_affiliation_strings":["Arzneimittelforschung Leipzig GmbH Leipzig Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arzneimittelforschung Leipzig GmbH Leipzig Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Feng Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Feng Zhang","raw_affiliation_strings":["Amgen Inc. Thousand Oaks CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc. Thousand Oaks CA United States","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002736298","display_name":"Hern\u00e0n Picard","orcid":"https://orcid.org/0000-0002-8912-7539","observed_orcids":["https://orcid.org/0000-0002-8912-7539"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hernan Picard","raw_affiliation_strings":["Amgen Inc. Thousand Oaks CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc. Thousand Oaks CA United States","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113649048","display_name":"Daniel D. Mikol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Mikol","raw_affiliation_strings":["Amgen Inc. Thousand Oaks CA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc. Thousand Oaks CA United States","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7861,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.72288831,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"90","issue":"15_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10852","display_name":"Temporomandibular Joint Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3603","display_name":"Complementary and Manual Therapy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erenumab","display_name":"erenumab","score":1.0},{"id":"https://openalex.org/keywords/episodic-migraine","display_name":"episodic migraine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.8849999904632568},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cgrp-receptor-antibody","display_name":"CGRP receptor antibody","score":0.8100000023841858},{"id":"https://openalex.org/keywords/migraine-treatment-efficacy","display_name":"migraine treatment efficacy","score":0.6259999871253967},{"id":"https://openalex.org/keywords/psychiatric-comorbidity","display_name":"psychiatric comorbidity","score":0.7089999914169312}],"concepts":[{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.7963756918907166},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.7023420333862305},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.6562889814376831},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5304723978042603},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45397356152534485},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4519039988517761},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.90.15_supplement.p4.105","doi":"https://doi.org/10.1212/wnl.90.15_supplement.p4.105","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.90.15_supplement.p4.105","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/17","display_name":"Partnerships for the goals","score":0.5099999904632568}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415995891","https://openalex.org/W2805440854","https://openalex.org/W4246825671","https://openalex.org/W4386003194","https://openalex.org/W4387692545","https://openalex.org/W4308954661","https://openalex.org/W2980838981","https://openalex.org/W2770965214","https://openalex.org/W4293229963","https://openalex.org/W4226002612"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"determine":[2],"efficacy":[3,146],"of":[4,43,69,94,111,116,121,125,512,514,546,548,580,582],"erenumab,":[5],"a":[6,336,381,415,443,492,526,560],"human":[7],"anti-CGRP":[8],"receptor":[9],"antibody,":[10],"in":[11,24,47,82,99,140,143,148,164,204,298,319,467],"episodic":[12],"migraine":[13,32,84,299],"(EM)":[14],"patients":[15,25,49,66,95,149,156,184,300],"with":[16,26,136,150,157,302,321,344,389,423,451,500,534,568],"depression":[17,27,70,126],"and/or":[18,71,127],"anxiety.":[19,128],"Background:":[20],"Determining":[21],"treatment":[22],"outcomes":[23],"and":[28,92,118,151,177,196,224,232,247,266,274,282,303,323,429,431],"anxiety,":[29],"two":[30],"common":[31],"comorbidities,":[33],"is":[34,296,317],"relevant":[35],"for":[36,60,75,105,169,174,180,206,211,233,271,287,332,377,411,439,471,488,507,522,541,556,575],"estimating":[37],"real-world":[38],"effectiveness.":[39],"Design/Methods:":[40],"Subgroup":[41],"analysis":[42],"phase":[44],"3":[45],"data":[46,64],"EM":[48],"randomized":[50],"1:1:1":[51],"to":[52,480],"erenumab":[53,138,295],"(70-mg":[54],"or":[55,57,341,386,420,448,497,531,565],"140-mg)":[56],"placebo":[58,112,170,212],"monthly":[59,83],"6":[61],"months.":[62],"Pre-specified":[63],"from":[65,77,402],"with/without":[67],"history":[68,124,208,236,273],"anxiety":[72],"(self-reported)":[73],"assessed":[74],"changes":[76,163,188,257],"baseline":[78],"over":[79],"months":[80],"4\u20136":[81],"days":[85,90],"(MMD),":[86],"acute":[87],"migraine-specific":[88],"medication":[89],"(MSMD),":[91],"proportion":[93],"achieving":[96],"\u226550%":[97],"reduction":[98,203],"MMD.":[100],"P":[101],"-values":[102],"not":[103],"adjusted":[104],"multiple":[106],"comparisons.":[107],"Results:":[108],"23%":[109],"(74/319)":[110],"patients,":[113],"18%":[114],"(58/317)":[115],"70-mg,":[117],"19%":[119],"(61/319)":[120],"140-mg":[122,181],"had":[123],"Baseline":[129],"characteristics":[130],"were":[131,166,189,209,237,258],"similar":[132],"among":[133],"groups.":[134],"Compared":[135],"placebo,":[137],"resulted":[139],"greater":[141],"improvement":[142],"all":[144],"three":[145],"measures":[147],"without":[152,185,304],"depression/anxiety":[153,158,186,207,235,272,289],"history.":[154,290],"In":[155,183],"history,":[159,187],"least-squares":[160],"mean":[161],"(SE)":[162],"MMD":[165],"\u22121.3":[167,262],"(0.4)":[168,173,179],"vs":[171,192,213,239,261,277],"\u22124.2":[172],"70-mg":[175],"(p<0.001)":[176,195],"\u22124.1":[178],"(p<0.001).":[182,199],"\u22122.0":[190],"(0.2)":[191,194,198,260],"\u22123.0":[193],"\u22123.6":[197],"Responder":[200],"rates":[201],"(\u226550%":[202],"MMD)":[205],"16%":[210],"54%":[214,225],"(70-mg:":[215,241,264,280],"odds":[216],"ratio":[217],"(95%":[218],"CI):":[219],"6.6":[220],"(2.8,":[221],"15.3);":[222],"p<0.001)":[223,231,265,270,281,286],"(140-mg:":[226,249,269,285],"OR:":[227,242,250],"6.0":[228],"(2.7,":[229],"13.5);":[230],"no":[234,288],"30%":[238],"41%":[240],"1.6":[243],"(1.1,":[244],"2.4);":[245],"p=0.010)":[246],"49%":[248],"2.3":[251],"(1.6,":[252],"3.3);":[253],"p<0.001).":[254],"Respective":[255],"MSMD":[256],"0.5":[259],"(0.3)":[263,268],"\u22121.5":[267],"\u22120.4":[275],"(0.1)":[276,279,284],"\u22121.1":[278],"\u22121.7":[283],"Conclusions:":[291],"Results":[292],"indicate":[293],"that":[294],"efficacious":[297],"both":[301],"depression/anxiety.":[305],"Study":[306],"Supported":[307],"by:":[308],"This":[309],"study":[310],"was":[311],"fully":[312],"funded":[313],"by":[314],"Amgen.":[315,404,501,515,535,549,569,583],"Erenumab":[316],"co-developed":[318],"partnership":[320],"Amgen":[322],"Novartis.":[324],"Disclosure:":[325],"Dr.":[326,354,371,396,405,433,456,461,476,482,502,516,536,550,570],"Tepper":[327],"has":[328,373,398,407,435,463,478,484,504,518,538,552,572],"received":[329,374,399,408,436,464,485,505,519,539,553,573],"personal":[330,375,409,437,465,486,520,554],"compensation":[331,376,410,438,466,487,506,521,540,555,574],"consulting,":[333,378,412,440,489,523,557],"serving":[334,379,413,441,490,508,524,542,558,576],"on":[335,380,414,442,491,509,525,543,559,577],"scientific":[337,382,416,444,493,527,561],"advisory":[338,383,417,445,494,528,562],"board,":[339,384,418,446,495,529,563],"speaking,":[340,385,419,447,496,530,564],"other":[342,387,421,449,498,532,566],"activities":[343,388,422,450,499,533,567],"Acorda,":[345],"Alder,":[346],"Allergan,":[347,392,452],"Amgen,":[348,425,453],"ATI,":[349,454],"Avanir,":[350,424,455],"BioVison,":[351],"Charleston":[352],"Laboratories,":[353],"Reddy\u2019s,":[355,457],"electroCore,":[356],"eNeura,":[357],"Eli":[358,427],"Lilly,":[359],"GLG,":[360],"Guidepoint":[361],"Global,":[362],"Kimberly-Clark,":[363],"Pernix,":[364],"Pfizer,":[365,391],"Scion":[366],"Neurostim,":[367],"Supernus,":[368],"Teva,":[369],"Zosano.":[370],"Broessner":[372,397],"Novartis,":[390,403,459],"Reckitt":[393],"Benkiser,Linde":[394],"AG.":[395],"research":[400],"support":[401],"Buse":[406],"Biohaven,":[426],"Lilly":[428],"Company":[430],"Promeius.":[432],"Schwedt":[434,462],"Nocira,":[458],"Teva.":[460],"an":[468],"editorial":[469],"capacity":[470],"Headache,":[472],"Pain":[473],"Medicine,":[474],"Cephalalgia.":[475],"Strauss":[477],"nothing":[479],"disclose.":[481],"Zhang":[483,503],"the":[510,544,578],"Board":[511,545,579],"Directors":[513,547,581],"Picard":[517,537],"Mikol":[551,571]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-26T11:51:55.731654","created_date":"2018-06-29T00:00:00"}